Fundraising Fox
One Chain
1 known investors
Find your way into One Chain
Sign up to see every warm intro you have to One Chain
- Paths you didn't know you had: your email and LinkedIn already hold routes to the One Chain team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OneChain Immunotherapeutics is a clinical-stage biotech developing CAR-T cell therapy candidates as treatments for oncological diseases. It is a spin-off from the Josep Carreras Leukemia Research Institute and ICREA, based on research led by Dr. Pablo Menéndez's team.
Founders & leadership
PM
Pablo MenéndezScientific Founder
Investors · 1
Frequently asked questions
- What does One Chain do?
- OneChain Immunotherapeutics is a clinical-stage biotech developing CAR-T cell therapy candidates as treatments for oncological diseases. It is a spin-off from the Josep Carreras Leukemia Research Institute and ICREA, based on research led by Dr. Pablo Menéndez's team.
- Who founded One Chain?
- One Chain was founded by Pablo Menéndez.
- Who are One Chain's investors?
- One Chain's investors include Invivo Capital Partners.